鼻窦炎质量测量:美国鼻科学会质量改进委员会综述
该综述检索了美国主要国家质量指标库与信息交换平台,并补充检索美国耳鼻咽喉头颈外科学会数据库、PubMed和Google,梳理急性与慢性鼻窦炎的质量测量现状。共识别出急性鼻窦炎7项、慢性鼻窦炎4项质量指标;急性指标集中于诊断适当性、抗生素处方和影像学检查,慢性指标集中于诊断适当性、影像学和患者生活质量测量。PQRS当前追踪3项急性鼻窦炎指标和1项慢性鼻窦炎指标,尚无结局导向指标及安全性、以患者为中心和及时性领域的指标。
要点
- 急性鼻窦炎质量指标主要针对抗生素处方(4项)与影像学检查(2项)。
- 慢性鼻窦炎指标聚焦诊断适当性、影像学与患者生活质量测量。
- 目前缺乏结局导向及安全性、以患者为中心、及时性领域的鼻窦炎质量指标。
核心结论
- 鼻窦炎质量测量目前主要集中于效率领域及急性鼻窦炎的过程指标。
- 未来需开发、验证并追踪结局导向质量指标以及慢性鼻窦炎特异性指标。
研究设计与样本
- 综述:检索美国主要国家质量指标库与信息交换平台,并补充检索美国耳鼻咽喉头颈外科学会数据库、PubMed和Google。
主要发现
- 共识别出急性鼻窦炎7项质量指标和慢性鼻窦炎4项质量指标。
- 急性鼻窦炎指标涉及诊断适当性(n=1)、抗生素处方(n=4)和影像学检查(n=2)。
- 慢性鼻窦炎指标涉及诊断适当性(n=1)、影像学检查(n=1)和患者生活质量测量(n=2)。
- PQRS当前追踪3项急性鼻窦炎指标和1项慢性鼻窦炎指标。
- 尚无结局导向的鼻窦炎质量指标,也无评估安全性、以患者为中心和及时性领域的指标。
关键数值与推荐
- 急性鼻窦炎质量指标7项:诊断适当性1项、抗生素处方4项、影像学检查2项。
- 慢性鼻窦炎质量指标4项:诊断适当性1项、影像学检查1项、患者生活质量测量2项。
- PQRS追踪急性鼻窦炎指标3项、慢性鼻窦炎指标1项。
临床怎么用
- 临床可参照现有急性鼻窦炎指标关注抗生素处方合理性与影像学检查适当性。
- 慢性鼻窦炎管理可关注诊断适当性与患者生活质量测量,但需注意结局指标尚缺。
局限性
- 无结局导向指标,且缺乏安全性、以患者为中心和及时性领域的指标。
- 慢性鼻窦炎特异性指标不足,未来指标开发仍面临重大缺口与挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Measuring quality outcomes is an important prerequisite to improve quality of care. Rhinosinusitis represents a high value target to improve quality of care because it has a high prevalence of disease, large economic burden, and large practice variation. In this study we review the current state of quality measurement for management of both acute (ARS) and chronic rhinosinusitis (CRS). METHODS: The major national quality metric repositories and clearinghouses were queried. Additional searches included the American Academy of Otolaryngology-Head and Neck Surgery database, PubMed, and Google to attempt to capture any additional quality metrics. RESULTS: Seven quality metrics for ARS and 4 quality metrics for CRS were identified. ARS metrics focused on appropriateness of diagnosis (n = 1), antibiotic prescribing (n = 4), and radiologic imaging (n = 2). CRS quality metrics focused on appropriateness of diagnosis (n = 1), radiologic imaging (n = 1), and measurement of patient quality of life (n = 2). The Physician Quality Reporting System (PQRS) currently tracks 3 ARS quality metrics and 1 CRS quality metric. There are no outcome-based rhinosinusitis quality metrics and no metrics that assess domains of safety, patient-centeredness, and timeliness of care. CONCLUSIONS: The current status of quality measurement for rhinosinusitis has focused primarily on the quality domain of efficiency and process measures for ARS. More work is needed to develop, validate, and track outcome-based quality metrics along with CRS-specific metrics. Although there has been excellent work done to improve quality measurement for rhinosinusitis, there remain major gaps and challenges that need to be considered during the development of future metrics.
引用
- Rudmik L, Mattos J, Schneider J, et al. Quality measurement for rhinosinusitis: a review from the Quality Improvement Committee of the American Rhinologic Society. Int Forum Allergy Rhinol. 2017. PMID: 28665549. doi:10.1002/alr.21983
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。